HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian O Ellis Selected Research

Fibrocystic Breast Disease (Chronic Cystic Mastitis)

1/2017Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family.
4/2016Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian O Ellis Research Topics

Disease

238Breast Neoplasms (Breast Cancer)
05/2022 - 01/2003
139Neoplasms (Cancer)
09/2021 - 04/2004
26Neoplasm Metastasis (Metastasis)
11/2020 - 03/2007
20Noninfiltrating Intraductal Carcinoma (DCIS)
05/2022 - 04/2008
15Carcinoma (Carcinomatosis)
01/2021 - 10/2003
11Triple Negative Breast Neoplasms
11/2021 - 01/2007
8Lobular Carcinoma
11/2020 - 05/2005
7Breast Ductal Carcinoma
05/2022 - 12/2018
7Carcinogenesis
02/2020 - 04/2008
7Ductal Carcinoma
01/2019 - 01/2008
6Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 04/2004
5Necrosis
01/2020 - 01/2018
4Disease Progression
10/2019 - 06/2004
4Genomic Instability
01/2019 - 01/2007
3Papillary Carcinoma
08/2020 - 08/2012
3Residual Neoplasm
11/2019 - 07/2016
3Lymphatic Metastasis
11/2018 - 03/2015
3Inflammation (Inflammations)
12/2015 - 01/2008
2Melanoma (Melanoma, Malignant)
08/2020 - 04/2012
2Margins of Excision
11/2019 - 01/2018
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2018 - 12/2014
2Male Breast Neoplasms (Male Breast Cancer)
05/2017 - 01/2017
2Acinar Cell Carcinoma
01/2017 - 10/2015
2Fibrocystic Breast Disease (Chronic Cystic Mastitis)
01/2017 - 04/2016
2Ovarian Neoplasms (Ovarian Cancer)
01/2015 - 10/2014

Drug/Important Bio-Agent (IBA)

100Proteins (Proteins, Gene)FDA Link
05/2022 - 09/2005
54Biological ProductsIBA
03/2021 - 06/2004
49Biomarkers (Surrogate Marker)IBA
09/2021 - 09/2005
43Estrogen ReceptorsIBA
09/2021 - 01/2005
34Messenger RNA (mRNA)IBA
01/2021 - 01/2007
32Phenobarbital (Luminal)FDA Link
09/2021 - 06/2004
21Hormones (Hormone)IBA
05/2022 - 09/2005
18Progesterone Receptors (Progesterone Receptor)IBA
07/2020 - 01/2007
16DNA (Deoxyribonucleic Acid)IBA
12/2018 - 05/2005
15human ERBB2 proteinIBA
11/2018 - 10/2007
14TamoxifenFDA LinkGeneric
09/2021 - 01/2007
13Cadherins (E-Cadherin)IBA
01/2019 - 05/2005
12Indicators and Reagents (Reagents)IBA
01/2019 - 04/2004
11Trastuzumab (Herceptin)FDA Link
11/2019 - 04/2010
10ErbB Receptors (EGF Receptor)IBA
07/2020 - 04/2004
8Phosphotransferases (Kinase)IBA
07/2020 - 04/2012
7Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2007
7AntibodiesIBA
05/2017 - 08/2008
7lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
01/2017 - 03/2013
7ParaffinIBA
01/2016 - 10/2003
6AnthracyclinesIBA
01/2020 - 08/2012
5Eosine Yellowish-(YS) (Eosin)IBA
12/2018 - 08/2010
5Estrogens (Estrogen)FDA Link
12/2015 - 07/2007
4Estrogen Receptor alphaIBA
11/2020 - 08/2008
4Cyclin EIBA
03/2020 - 02/2017
4Glutamine (L-Glutamine)FDA Link
01/2020 - 01/2018
4CollagenIBA
10/2019 - 11/2007
4CateninsIBA
07/2013 - 10/2010
4Keratins (Keratin)IBA
05/2013 - 10/2003
4Monoclonal AntibodiesIBA
02/2013 - 04/2004
3Amino Acid Transport Systems (Amino Acid Transporter)IBA
09/2021 - 01/2018
3MucinsIBA
07/2020 - 10/2005
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019 - 04/2015
3Cyclin D1IBA
01/2019 - 04/2008
3Tumor Biomarkers (Tumor Markers)IBA
12/2017 - 05/2009
3CalpainIBA
01/2017 - 10/2011
3RecQ HelicasesIBA
01/2017 - 03/2016
3Serine (L-Serine)FDA Link
02/2016 - 03/2015
3Fulvestrant (Faslodex)FDA Link
01/2016 - 07/2007
3Estrogen Receptor Modulators (Antiestrogen)IBA
12/2015 - 07/2007
3Protein Isoforms (Isoforms)IBA
03/2015 - 08/2008
3Pharmaceutical PreparationsIBA
03/2015 - 03/2010
3MicroRNAs (MicroRNA)IBA
01/2013 - 01/2007
3Epidermal Growth Factor (EGF)IBA
08/2012 - 03/2007
3Steroid Receptors (Steroid Receptor)IBA
01/2010 - 08/2008
3Complement System Proteins (Complement)IBA
01/2007 - 07/2005
2TensinsIBA
07/2020 - 02/2011
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 01/2019
2Large Neutral Amino Acid-Transporter 1IBA
02/2020 - 01/2018
2Dihydrotachysterol (AT 10)IBA
01/2020 - 07/2016
2zinc-binding protein (zinc binding protein)IBA
01/2019 - 07/2007
2ThioredoxinsIBA
12/2018 - 08/2011
2GTP-Binding Proteins (G-Protein)IBA
05/2018 - 04/2015
2CytokinesIBA
04/2018 - 01/2011
2Gefitinib (Iressa)FDA Link
01/2018 - 01/2007
24- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
08/2016 - 04/2016
2taxaneIBA
07/2016 - 04/2013
2ChromatinIBA
01/2016 - 01/2012
2Formaldehyde (Formol)FDA Link
01/2016 - 01/2011
2Peptides (Polypeptides)IBA
05/2015 - 04/2004
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2015 - 07/2007
2erucylphosphocholineIBA
04/2015 - 08/2012
2Flap EndonucleasesIBA
12/2014 - 10/2014
2DNA-Activated Protein KinaseIBA
12/2014 - 07/2014
2DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
12/2014 - 05/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2014 - 04/2010
2Methotrexate (Mexate)FDA LinkGeneric
11/2014 - 04/2010

Therapy/Procedure

70Therapeutics
11/2021 - 10/2005
18Drug Therapy (Chemotherapy)
11/2020 - 10/2007
9Radiotherapy
11/2019 - 01/2011
6Adjuvant Chemotherapy
11/2019 - 10/2007
5Segmental Mastectomy (Lumpectomy)
01/2019 - 04/2011
4Neoadjuvant Therapy
01/2021 - 08/2012
2Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 01/2019
2Mastectomy (Mammectomy)
11/2019 - 05/2010